IT @ Networking Awards 2012 - Raise Awareness of the World's Most Innovative Healthcare IT Projects

18 - 19 January 2012, Brussels, Belgium.
The IT @ Networking Awards 2012 (IT @ 2012) is an open competition for implemented, fully operable healthcare IT and medical technology solutions in healthcare. The goal is to raise awareness of some of the world's finest and most innovative local, regional and national healthcare IT projects.

Recognition
High-tech, high-cost medicine; ageing populations; patient mobility and staff shortages are only some of the challenges healthcare providers face today. Intelligent IT solutions increase cost-effectiveness, productivity and safety and help healthcare facilities to confront these problems. IT @ 2012 brings these innovations into the global spotlight and provides them with the recognition and media attention they deserve.

Their stories will inspire others, proving that challenges can be transformed into future opportunities and success stories.

Novel and Interactive
The core aim of IT @ 2012 is to learn from the mistakes and achievements of different top IT installations. The unique peer-to-peer voting system empowers daily users such as CEOs, CIOs, CMIOs, hospital and IT managers to vote for their preferred projects, as they are best placed to judge the real value of projects.

First Day - MindByte Session
All Nominees will present in the MindByte, a five minute introductory presentation followed by a lively five minute Q&A. The qualifying audience will vote immediately after each presentation according to the voting criteria for their favourite solution.

Becoming a Nominee is a huge achievement and each will be awarded the prestigious IT @ 2012 Nominee Silver Medal.

Second Day - WorkBench Session
The nine top-rated Nominees will progress as Finalists into the next day WorkBench, a 30-minute in-depth presentation followed by a 15 minute Q&A discussion, providing the audience with a thorough understanding of the project. The qualifying audience will vote immediately after each presentation to choose the winners. Finalists will be awarded the prestigious IT @ 2012 Finalist Gold Medal.

The Prize
The top three IT solutions will be awarded a prize.

The winning Project will receive:

  • The IT @ Networking Awards 2012 Trophy;
  • A cash prize of € 5,000;
  • Media promotion in Europe's leading healthcare management media worth € 50,000.

The 2nd Project will receive:

  • The IT @ Networking Awards 2012 Trophy;
  • Media promotion in europe’s leading healthcare management media worth € 25,000.

The 3rd Project will receive:

  • The IT @ Networking Awards 2012 Trophy.

For further information, please visit:
http://www.itandnetworking.org

Most Popular Now

GSK reaches agreement with Novartis to acquire ful…

GlaxoSmithKline plc (LSE/NYSE: GSK) today announces that it has reached an agreement with Novartis for the buyout of Novartis' 36.5% stake in their Consumer Healthcare Jo...

Canadian neuroscientists say daily ibuprofen can p…

A Vancouver-based research team led by Canada's most cited neuroscientist, Dr. Patrick McGeer, has successfully carried out studies suggesting that, if started early enou...

First proof a synthesized antibiotic is capable of…

A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time - and could lea...

Merck partners with Medisafe to help improve medic…

Merck, a leading science and technology company, today announced a new collaboration with US-based Medisafe to help its cardiometabolic patients better manage medication ...

Phase III data in The Lancet show Novartis siponim…

Novartis today announced that the full results from the Phase III EXPAND study of oral, once-daily siponimod (BAF312) in secondary progressive multiple sclerosis (SPMS) w...

Taking a standard prostate cancer drug with food b…

By taking a high-cost drug with a low-fat meal - instead of on an empty stomach, as prescribed - prostate cancer patients could decrease their daily dose, prevent digesti...

New immunotherapy for lung cancer shows promise of…

In a groundbreaking development, results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at contro...

Boehringer Ingelheim and OSE Immunotherapeutics an…

Boehringer Ingelheim and OSE Immunotherapeutics, a biotechnology company focused on the development of innovative immunotherapies, have announced a collaboration and excl...

Personalized tumor vaccine shows promise in pilot …

A new type of cancer vaccine has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and...

New targeted therapy schedule could keep melanoma …

Skin melanoma, a particularly insidious cancer, accounts for the vast majority skin cancer deaths and is one of the most common cancers in people under 30. Treatment for ...

Researchers identify chemical compound that inhibi…

An organic chemical compound shows effective antiviral activity against Ebola virus and several other viruses, according to a study led by Georgia State University. The r...

When drugs are wrong, skipped or make you sick: Th…

Rising drug prices have gotten a lot of attention lately, but the actual cost of prescription medications is more than just the dollars and cents on the bill. Researchers...